Hjem › Pladecellekarcinom › Pennsylvania › Pittsburgh
Pladecellekarcinom kliniske forsøg i Pittsburgh, PA
10 studier for Pladecellekarcinom søger deltagere på steder i og omkring Pittsburgh (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site, Pittsburgh
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
RekruttererFase 2
- UPMC Hillman Cancer Center, Pittsburgh
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
RekruttererFase 1Frivillige med god helbredstilstand velkomne
- St. Margaret Hospital Dermatology, Pittsburgh
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
RekruttererFase 2
- UPMC Hillman Cancer Center - Radiation Oncology, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
RekruttererFase 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekruttererFase 3
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
RekruttererFase 1
- UPMC- Hillman Cancer Center, Pittsburgh
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
RekruttererFase 2
- UPMC, Pittsburgh
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RekruttererFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Pladecellekarcinom forsøg i andre byer
- Los Angeles, CA8 studier
- Boston, MA8 studier
- Houston, TX7 studier
- New York City, NY7 studier
- Nashville, TN7 studier
- Atlanta, GA5 studier
- Durham, NC4 studier
- Arlington, VA4 studier
- Tampa, FL4 studier
- Orlando, FL4 studier
- Queens, NY4 studier
- Washington, DC4 studier
Andre studier i Pittsburgh
- Ikke-småcellet lungecancer48 studier
- Kræft (alle typer)41 studier
- Brystkræft39 studier
- Colorektal kræft32 studier
- Metastatisk cancer31 studier
- Melanom31 studier
- Ægstockræft30 studier
- Livmoderslimhindekræft23 studier
- Lungecancer23 studier
- Prostatakræft23 studier
- Slagtilfælde22 studier
- Pladecellekræft i hoved og hals22 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.